RescueTEE for In-hospital Cardiac Arrest (ReTEECA Trial)
Launched by UNIVERSITY OF PENNSYLVANIA · Jan 4, 2020
Trial Information
Current as of June 17, 2025
Withdrawn
Keywords
ClinConnect Summary
This is a Phase II, single center, partially blinded, prospective, safety and efficacy pragmatic clinical trial comparing rescue transesophageal image guided ACLS versus conventional ACLS in adult patients with in-hospital cardiac arrest (IHCA). The ReTEECA Trial will use a recently published and validated focused 5-view RescueTEE protocol to evaluate patients with IHCA to obtain diagnostic and therapeutic information to aid in medical decision-making in a rapid fashion for those patients who are experiencing in-hospital arrest.1 Patients will be resuscitated with one of the following proto...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients greater than 18 years of age;
- • Intubated or permanent tracheostomy in situ;
- • Experiencing extreme hemodynamic instability, cardiac arrest, or respiratory arrest and TTE is difficult or contraindicated
- • Rapid response, Code calls, ECMO stat evaluation
- • In-patients
- Exclusion Criteria:
- • Unsecured airway
- • On-going aspiration
- • History of tracheoesophageal injury
- • History of tracheoesophageal fistula
- • Esophagectomy
- • Active upper GI bleeding
- • Esophageal varices
- • Ongoing hemoptysis
- • Technically challenging TEE placement due to location of code - Small room, intrusive to the code team, airway trauma
About University Of Pennsylvania
The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Jacob Gutsche, MD
Principal Investigator
University of Pennsylvania, Department of Anesthesiology and Critical Care
Asad A Usman, MD, MPH
Principal Investigator
University of Pennsylvania, Department of Anesthesiology and Critical Care
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials